STAT+: Biospring Partners closes $245 million first fund as private markets tense up

BioSpring Partners closes $245 million first fund as private markets tense up.

When Michelle Dipp and Jennifer Lum decided to launch a life sciences growth equity fund two years ago, the market looked very different.

The Covid-19 pandemic was driving investors in droves to biotech and pharma companies. Automation and drug manufacturing were becoming hot topics.

Continue to STAT+ to read the full story…